Logo image of IPHA

INNATE PHARMA SA-SPONS ADR (IPHA) Stock Analyst Ratings

USA - NASDAQ:IPHA - US45781K2042 - ADR

2.07 USD
-0.02 (-0.96%)
Last: 10/29/2025, 4:08:00 PM
2.08 USD
+0.01 (+0.48%)
After Hours: 10/29/2025, 4:08:00 PM
Buy % Consensus

74

ChartMill assigns a Buy % Consensus number of 74% to IPHA. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 6.12. This target is 195.53% above the current price.
IPHA was analyzed by 7 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about IPHA.
In the previous month the buy percentage consensus was at a similar level.
IPHA was analyzed by 7 analysts. More opinions would make the average more meaningful.
IPHA Historical Analyst RatingsIPHA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -106 -96 -86 -76 -66 -56 -46 -36 -26 -16 -6 2 4 6 8 10

Price Target & Forecast

Price Low Median Mean High 2.072.776.126.129.72 - 33.82% 195.53% 195.53% 369.33%
IPHA Current Analyst RatingIPHA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5
Up and Down Grades
Date Firm Action Rating
2025-10-29 BTIG Reiterate Buy -> Buy
2025-10-29 HC Wainwright & Co. Upgrade Neutral -> Buy
2025-09-18 Leerink Partners Downgrade Outperform -> Market Perform
2025-09-18 HC Wainwright & Co. Downgrade Buy -> Neutral
2025-04-24 HC Wainwright & Co. Reiterate Buy -> Buy
2025-03-28 HC Wainwright & Co. Reiterate Buy -> Buy
2025-02-06 HC Wainwright & Co. Reiterate Buy -> Buy
2025-01-17 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-09 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-09-13 HC Wainwright & Co. Reiterate Buy -> Buy
2024-06-12 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-15 HC Wainwright & Co. Reiterate Buy -> Buy
2024-04-11 HC Wainwright & Co. Reiterate Buy -> Buy
2024-03-22 HC Wainwright & Co. Reiterate Buy -> Buy
2023-11-15 HC Wainwright & Co. Reiterate Buy -> Buy
2023-09-18 HC Wainwright & Co. Reiterate Buy -> Buy
2023-06-16 HC Wainwright & Co. Reiterate Buy -> Buy
2023-03-24 HC Wainwright & Co. Reiterate Buy
2022-11-15 SVB Leerink Maintains Outperform
2022-09-16 Citigroup Maintains Buy
2022-08-02 SVB Leerink Maintains Outperform
2022-05-11 SVB Leerink Maintains Outperform
2021-09-17 SVB Leerink Maintains Outperform
2021-09-03 SVB Leerink Upgrade Market Perform -> Outperform
2021-09-02 SVB Leerink Upgrade Market Perform -> Outperform

INNATE PHARMA SA-SPONS ADR / IPHA FAQ

What is the average price target for INNATE PHARMA SA-SPONS ADR (IPHA) stock?

7 analysts have analysed IPHA and the average price target is 6.12 USD. This implies a price increase of 195.53% is expected in the next year compared to the current price of 2.07.


What is the consensus rating for IPHA stock?

The consensus rating for INNATE PHARMA SA-SPONS ADR (IPHA) is 74.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.


Can you provide the analyst count for INNATE PHARMA SA-SPONS ADR stock?

The number of analysts covering INNATE PHARMA SA-SPONS ADR (IPHA) is 7.